Cancer Cell Targeting Articles & Analysis
12 news found
Combined with nanotechnology, "smart" drugs can actively target tumors by binding to corresponding receptors on tumor cells through interactions with phenotype-specific ligands conjugated to the delivery vehicle. ...
Expanding the Horizon with Advanced Anti-Tumor APIs Protheragen-ING’s new anti-tumor APIs are a quantum leap forward for cancer therapy. Such APIs come in a wide range of types: chemotherapeutic, targeted, immunotherapeutic, hormone therapeutic. The APIs in chemotherapy work by interfering with the cell division mechanism to suppress ...
CX-904 is a conditionally activated T-cell-engaging bispecific (TCB) designed to target the epidermal growth factor receptor (EGFR) on cancer cells and the CD3 receptor on T cells within the tumor microenvironment. ...
It is a potent anticancer drug that targets cancer cells at a specific site, and is considered to be an important means of disease treatment in the future. ...
It will be the first proton therapy system in San Antonio and South Texas to provide this advanced alternative to conventional radiation therapy for cancer. Proton therapy targets cancer cells more precisely than traditional x-ray photon therapy, and results in less damage to surrounding healthy tissue and sensitive organs ...
GammaTiles, postage stamp-sized 3D collagen tiles embedded with radiation seeds, directly target cancer cells at the tumor cavity site. They are implanted by the surgeon and deliver ninety percent of the radiation dose in 33 days. ...
Lentiviruses are widely used as a tool to deliver genes of interest to cells. In this case, the lentivirus transduces (or inserts) a group of genes to a patient’s T cells (immune cells), which turn the T cells into cancer-killing CAR-T cells targeting LGR5, a ...
Jean-Christophe Hyvert, President, Biologics and Cell & Gene Divisions, Lonza, commented: “This expanded customer relationship truly exemplifies our value and capabilities as a strategic partner on the path to commercialization. ...
Preloaded in the CSS are treatment-dosage protocols for over 30 different cancer types and a robotic assisted image-guided navigational mapping system that delivers personalized and targeted CHCAP cancer treatments directly to the surgical site and ablating any remaining cancer cells after the tumor is removed ...
After the surgeon removes the cancerous tumor during surgery, CHCP is subsequently sprayed at the surgical margins to target any remaining cancerous tissue or cells, thus reducing the chances of cancer recurrence. ...
” nfP2X7 is a tumour-specific target, discovered by Biosceptre, that’s found on a wide range of cancers, both haematological and solid. Studies have shown that it retains critical signalling capabilities that support cancer cell survival and possesses novel epitopes that are available for antibody binding. ...
The inventors set out to solve a fundamental challenge to the rapid and cost-effective delivery of care to cancer patients: insufficient tissue from biopsy procedures. Pathologists receive minuscule amounts of tissue from needle biopsy procedures, insufficient to perform the sophisticated diagnostic tests required for personalized medicine that oncologists prefer to precisely ...